Current and Future Trends in Whole Genome Sequencing in Cancer

Overview

Journal Cancer Biol Med

Specialty Oncology

Date 2024 Feb 15

PMID 38356245

Authors

Yuki Katsuya

Affiliations

Soon will be listed here.

References

Satam H, Joshi K, Mangrolia U, Waghoo S, Zaidi G, Rawool S . Next-Generation Sequencing Technology: Current Trends and Advancements. Biology (Basel). 2023; 12(7). PMC: 10376292. DOI: 10.3390/biology12070997. View

Hamdan A, Ewing A . Unravelling the tumour genome: The evolutionary and clinical impacts of structural variants in tumourigenesis. J Pathol. 2022; 257(4):479-493. PMC: 9321913. DOI: 10.1002/path.5901. View

Samsom K, Schipper L, Roepman P, Bosch L, Lalezari F, Klompenhouwer E . Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice. J Pathol. 2022; 258(2):179-188. PMC: 9546477. DOI: 10.1002/path.5988. View

Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X . Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016; 534(7605):47-54. PMC: 4910866. DOI: 10.1038/nature17676. View

. Pan-cancer analysis of whole genomes. Nature. 2020; 578(7793):82-93. PMC: 7025898. DOI: 10.1038/s41586-020-1969-6. View

Mayor S . Genome sequence of one individual is published for first time. BMJ. 2007; 335(7619):530-1. PMC: 1976501. DOI: 10.1136/bmj.39335.753009.94. View

Nakagawa H, Fujita M . Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer Sci. 2018; 109(3):513-522. PMC: 5834793. DOI: 10.1111/cas.13505. View

Cuppen E, Elemento O, Rosenquist R, Nikic S, IJzerman M, Zaleski I . Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care. JCO Precis Oncol. 2022; 6:e2200245. PMC: 10166391. DOI: 10.1200/PO.22.00245. View

Schipper L, Samsom K, Snaebjornsson P, Battaglia T, Bosch L, Lalezari F . Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics. ESMO Open. 2022; 7(6):100611. PMC: 9808446. DOI: 10.1016/j.esmoop.2022.100611. View

10.

Rheinbay E, Nielsen M, Abascal F, Wala J, Shapira O, Tiao G . Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature. 2020; 578(7793):102-111. PMC: 7054214. DOI: 10.1038/s41586-020-1965-x. View

11.

Turnbull C, Scott R, Thomas E, Jones L, Murugaesu N, Pretty F . The 100 000 Genomes Project: bringing whole genome sequencing to the NHS. BMJ. 2018; 361:k1687. DOI: 10.1136/bmj.k1687. View

12.

Sakamoto Y, Xu L, Seki M, Yokoyama T, Kasahara M, Kashima Y . Long-read sequencing for non-small-cell lung cancer genomes. Genome Res. 2020; 30(9):1243-1257. PMC: 7545141. DOI: 10.1101/gr.261941.120. View

13.

Zverinova S, Guryev V . Variant calling: Considerations, practices, and developments. Hum Mutat. 2021; 43(8):976-985. PMC: 9545713. DOI: 10.1002/humu.24311. View

14.

Jones S, Laskin J, Li Y, Griffith O, An J, Bilenky M . Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol. 2010; 11(8):R82. PMC: 2945784. DOI: 10.1186/gb-2010-11-8-r82. View